CREO MEDICAL GROUP PLC (CREO) — Interim results for the six months ended 30 June 2025

Investor webinar replay

Replay transcript excerpt

Good afternoon, and welcome to the CREO MEDICAL GROUP PLC Investor Presentation. Throughout this recorded presentation, investors will be in listen only mode. Questions are encouraged and could be submitted at any time via the Q and A tab situated on the right hand corner of your screen. Simply type in your questions and press send. The company may not be in a position to answer every question that receives during the meeting itself. However, the company can review all questions submitted today and publish responses where it's appropriate to do so. Before we begin, I'd like to submit the following poll. I'd now like to hand you over to Craig Gulliford, CEO. Good afternoon, sir. Good afternoon. Thanks, Lily. Thanks for the introduction, and good afternoon, everybody. So, yeah, welcome to our interim results for the first half of twenty twenty five. Happy to say that, you know, the first half of the of the year, first two quarters on budget for the previous two or three quarters before that were on budget, so we're delivering time after time. I know there's an expectation and the need for everybody to see us continue to grow the business, grow the business faster if we can. But at the end of the day, we're executing on our quarterly, quarterly, quarterly by quarterly results. And we've got high confidence for the second half of the year. Obviously, we're close to the end of Q3. We're not changing guidance, but we're we're confident of where we're we're heading when we look at the guidance. And I know there's a range out there that people are asking about, but that's where we are. We're the early stages of this kind of ramp up in our revenue. If I look at the the product range as you see here, we've got multiple indications, multiple products. It's interesting that the ...